Advanced glycated end‐products inhibit dilation through constitutive endothelial RAGE and Nox1/4 in rat isolated skeletal muscle arteries
Microcirculation · 2024-01 · 31 (1)
DOI: 10.1111/micc.12837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microcirculation, online erschienen am 20.11.2023. Verfasst von Nadim Naser und 4 weiteren Autor:innen. Beteiligte Einrichtung: Physiology, School of Biomedical Sciences, UNSW Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Acetophenones, Benzamides, Endothelial Cells, Endothelium, Vascular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Foundation of Australia.
Abstract (Originalsprache)
Objective
This study investigated the actions of advanced glycated end‐products (AGE), their receptors (RAGE), and NAD(P)H oxidase (Nox) subtypes 1, 2, and 4 on mechanisms of endothelium‐dependent dilation of the rat cremaster muscle artery (CMA).
Methods
Immunofluorescence studies were used to examine expression of RAGE in rat arteries. ROS accumulation was measured using luminescence and fluorescence assays. Functional studies were performed using pressure myography.
Results
High levels of RAGE expression were shown in the endothelial cells of the CMA, compared with low endothelial expression in middle cerebral and mesenteric arteries and the aorta. Exogenous AGE (in vitro glycated bovine serum albumin) stimulated H2O2 accumulation in CMA, which was prevented by the RAGE antagonist FPS‐ZM1, the NAD(P)H oxidase (Nox) inhibitor apocynin and inhibited by the Nox1/4 inhibitor setanaxib, but not the Nox2 inhibitor GSK2795039. In functional studies, AGE inhibited vasodilation of CMA stimulated by acetylcholine, sodium nitroprusside, and the BKCa activator NS1619, but not adenosine‐induced dilation. FPS‐ZM1, apocynin, and setanaxib prevented the inhibitory effects of AGE on responses to acetylcholine and NS‐1619.
Conclusion
These observations suggest RAGE are constitutively expressed in the endothelium of the rat CMA and may be activated by AGE to stimulate Nox1/4 and ROS formation with resulting inhibition of NO and BKCa‐mediated endothelium‐dependent dilation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Physiology, School of Biomedical Sciences, UNSW Sydney, Sydney, Australia.
- Townsville University Hospital, Townsville, Queensland, Australia.
- Biomedical Science, University of the Sunshine Coast, Maroochydore, Australia.
- Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
ORCID-Profile: Timothy V Murphy
Förderung
- National Heart Foundation of Australia
Zitieren
APA
Naser, N., Lonj, C. K., Rikard-Bell, M., Sandow, S. L., & Murphy, T. V. (2024). Advanced glycated end‐products inhibit dilation through constitutive endothelial RAGE and Nox1/4 in rat isolated skeletal muscle arteries. Microcirculation, 31(1). https://doi.org/10.1111/micc.12837
Vancouver
Naser N, Lonj CK, Rikard-Bell M, Sandow SL, Murphy TV. Advanced glycated end‐products inhibit dilation through constitutive endothelial RAGE and Nox1/4 in rat isolated skeletal muscle arteries. Microcirculation. 2024;31(1). doi:10.1111/micc.12837
BibTeX
@article{Naser2024,
author = {Naser, Nadim and Lonj, Chenchel K and Rikard-Bell, Matthew and Sandow, Shaun L and Murphy, Timothy V},
title = {Advanced glycated end‐products inhibit dilation through constitutive endothelial RAGE and Nox1/4 in rat isolated skeletal muscle arteries},
journal = {Microcirculation},
year = {2024},
volume = {31},
number = {1},
doi = {10.1111/micc.12837}
}
EUVIMED